Appriss, INC.

Innovative technology solutions provider.

Based in KY

🤖

AI Overview

With $590K in lobbying spend across 16 quarterly filings, Appriss, INC is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2018 to 2021.

$590K
Total Spend
4
Years Active
1
Firms Hired
7
Lobbyists Deployed
3
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$200K
2019$240K
2020$110K
2021$40K

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Appriss, INC. disclosed contacting in their lobbying filings.

Centers For Medicare and Medicaid Services (CMS)Health & Human Services, Dept of (HHS)HOUSE OF REPRESENTATIVESNatl Security Council (NSC)Office of Natl Drug Control Policy (NDCP)SENATEWhite House OfficeFood & Drug Administration (FDA)Veterans Affairs, Dept of (VA)Justice, Dept of (DOJ)Indian Health ServiceGovernment Accountability Office (GAO)
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Pharmacy, Government Issues, Veterans

Prescription drug monitoring programs and related legislation, including Energy & Commerce PDMP discussion draft (Reps. Griffith-Pallone) and the Opioid Crisis Response Act.

Legislation related to prescription drug monitoring programs, including H.R. 6, S. 3120, and S. 2680.

Legislation related to prescription drug monitoring programs, including H.R. 6, H.R.6688, and S. 2372.

Issues related to Bureau of Justice Assistance grant for state prescription drug monitoring programs.

Legislation related to prescription drug monitoring programs, including H.R. 6.

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.